VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer
- PMID: 64298
VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer
Similar articles
-
[VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].Schweiz Med Wochenschr. 1977 Jul 2;107(26):912-5. Schweiz Med Wochenschr. 1977. PMID: 877537 German.
-
VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.Semin Oncol. 1985 Mar;12(1 Suppl 2):37-41. Semin Oncol. 1985. PMID: 2579442
-
ICRF-159 versus polychemotherapy in non-small cell lung cancer.Cancer Treat Rep. 1976 Jul;60(7):947-8. Cancer Treat Rep. 1976. PMID: 64297 Clinical Trial. No abstract available.
-
The role of chemotherapy in the treatment of lung cancer.Semin Oncol. 1974 Sep;1(3):259-72. Semin Oncol. 1974. PMID: 4143488 Review. No abstract available.
-
Advances in cancer chemotherapy.J Med Liban. 1975;28(1):9-24. J Med Liban. 1975. PMID: 54428 Review. No abstract available.
Cited by
-
Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.Drugs. 1990 Mar;39(3):438-90. doi: 10.2165/00003495-199039030-00008. Drugs. 1990. PMID: 2184009 Review. No abstract available.
-
Biodistribution of O6-benzylguanine and its effectiveness against human brain tumor xenografts when given in polyethylene glycol or cremophor-EL.Cancer Chemother Pharmacol. 1994;35(2):121-6. doi: 10.1007/BF00686633. Cancer Chemother Pharmacol. 1994. PMID: 7987987
-
Epipodophyllotoxin (VP16-213) in small cell carcinoma of the Bronchus resistant to initial combination chemotherapy.Cancer Chemother Pharmacol. 1982;7(2-3):179-80. doi: 10.1007/BF00254544. Cancer Chemother Pharmacol. 1982. PMID: 6282480
-
Etoposide: current status and future perspectives in the management of malignant neoplasms.Cancer Chemother Pharmacol. 1994;34 Suppl:S118-26. doi: 10.1007/BF00684875. Cancer Chemother Pharmacol. 1994. PMID: 8070020 Review.
-
[Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].Klin Wochenschr. 1981 Nov 2;59(21):1177-88. doi: 10.1007/BF01721212. Klin Wochenschr. 1981. PMID: 7031350 Clinical Trial. German.